Outpatient follow-up of hypertensive patients by a primary care physician. Guidelines

The guidelines have been developed to standardize and optimize approaches to the follow-up of hypertensive outpatients. They are based on the latest Russian clinical guidelines, standards and procedures for the healthcare provision. Key attention is paid to outpatient follow-up, risk factors, prevention of complications, as well as drug and non-drug treatment.

The guidelines present algorithms for outpatient follow-up, methods for blood pressure monitoring, criteria for drug and non-drug therapy prescription, as well as approaches to medical rehabilitation. Particular attention is paid to an individualized approach, adherence to therapy, monitoring the effectiveness of treatment and interdisciplinary interaction.

The guidelines are intended for district internists, general practitioners (family doctors), district internists of the shop medical district, as well as for secondary medical personnel working with these doctors, for paramedics of paramedic- obstetric stations (paramedic health centers) in case they are assigned the functions of the attending physician.

The guidelines can be used by public health physicians, heads of primary health care facilities and their divisions.

1. Kobalava ZhD, Konradi AO, Nedogoda SV, et al. 2024 Clinical practice guidelines for Hypertension in adults. Russian Journal of Cardiology. 2024;29(9):6117. (In Russ.)

2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-r epresentative studies with 104 million participants. Lancet. 2021;398:957-80. doi:10.1016/S0140-6736(21)01330-1.

3. Muromtseva GA, Kontsevaya AV, Konstantinov VV, et al. The prevalence of noninfectious diseases risk factors in Russian population in 2012-2013 years. The results of ECVD-RF. Cardiovascular Therapy and Prevention. 2014;13(6):4-11. (In Russ.)

4. Pan H, Hibino M, Kobeissi E, et al. Blood pressure, hypertension and the risk of sudden cardiac death: a systematic review and meta-analysis of cohort studies. European Journal of Epidemiology. 2020;35(5):443-54. doi:10.1007/s10654-01900593-4.

5. Cardiology: a guide for doctors. Eds. R. G. Oganov, I. G. Fomina. M.: Medicine, 2004. 848 p. (In Russ.)

6. McEvoy JW, McCarthy CP, Bruno RM, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. European Heart Journal. 2024;45(38):3912-4018. doi:10.1093/eurheartj/ehae178.

7. Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874-2071. doi:10.1097/HJH.0000000000003480.

8. Drapkina OM, Berns SA, Nikulina SYu, Solovieva EYu. Screening algorithm for predementia cognitive impairment in cardiovascular patients at a general practitioner’s appointment. Expert Consensus Statement. Cardiovascular Therapy and Prevention. 2024;23(10):4132. (In Russ.)

9. Ostroumova OD, Parfenov VA, Ostroumova TM, et al. Expert consensus. Effect of antihypertensive therapy on cognitive functions. Systemic Hypertension. 2021;18(1):5-12. (In Russ.) Остроумова О. Д., Парфенов В. А., Остроумова Т. М. и др. Консенсус экспертов. Влияние антигипертензивной терапии на когнитивные функции. Системные гипертензии. 2021;18(1):5-12. doi:10.26442/2075082X.2021.1.200575.

10. Rouch L, Cestac P, Sallerin B, et al; S.AGES investigators. Visit-to-V isit Blood Pressure Variability Is Associated With Cognitive Decline and Incident Dementia: The S.AGES Cohort. Hypertension. 2020;76(4):1280-8. doi:10.1161/HYPERTENSIONAHA.119.14553.

11. Bogolepova AN, Illarioshkin SN, Poluektov MG, et al. Mechanisms of development of cognitive disorders and the possibility of their pharmacological correction using the drug Miladean on the way from the pre-dementia stage to dementia. Nervous diseases. 2023;(4):18-28. (In Russ.)

12. Mortensen MB, Tybjærg-H ansen A, Nordestgaard BG, et al. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. European heart journal. 2021;42(25):2439-54. doi:10.1093/eurheartj/ ehab309 9.

13. Svinin GE, Kutsenko VA, Shalnova SA, et al. Validation of SCORE2 on a sample from the Russian population and adaptation for the very high cardiovascular disease risk region. PLoS One. 2024;19(4):e0300974. doi:10.1371/journal.pone.0300974.

14. Conroy RM, Fitzgerald AP, Graham IM, et al. Estimation of ten-year risk of fatal cardiovascular disease in europe: the score project. European Heart Journal. 2003;24(11):987-1003. doi: 10.1016/s0195-668x(03)00114-3.

15. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European heart journal. 2020;41:111-88. doi:10.1093/eurheartj/ehz455.

16. Posokhov IN, Praskurnichiy EA. What's changed in home blood pressure monitoring over the decade? Russian Journal of Cardiology. 2024;29(3S):5966. (In Russ.)

17. Gorbunov VM, Smirnova MI, Kurekhyan AS, Drapkina OM. Evaluation of office and ambulatory blood pressure in the practice of a primary care physician. Guidelines. Cardiovascular Therapy and Prevention. 2023;22(7):3666. (In Russ.)

18. Fowkes FG, Aboyans V, Fowkes FJ, et al. Peripheral artery disease: epidemiology and global perspectives. Nature reviews. Сardiology. 2017;14(3):156-70. doi:10.1038/nrcardio.2016.179.

19. Lukina YuV, Kutishenko NP, Martsevich SYu, Drapkina OM. The Questionnaire Survey Method in Medicine on the Example of Treatment Adherence Scales. Rational Pharmacotherapy in Cardiology. 2021;17(4):576-83. (In Russ.)

20. Drapkina OM, Karamnova NS, Kontsevaya AV, et al. Russian Society for the Prevention of Noncommunicable Diseases (ROPNIZ). Alimentary-d ependent risk factors for chronic non-communicable diseases and eating habits: dietary correction within the framework of preventive counseling. Methodological Guidelines. Cardiovascular Therapy and Prevention. 2021;20(5):2952. (In Russ.)

21. Bubnova MG, Aronov DM. Cardiorehabilitation: stages, principles and international classification of functioning (ICF). Preventive medicine. 2020;23(5):409. (In Russ.)

22. Franklin BA, Brubaker PH, Harber MP, et al. The Journal of Cardiopulmonary Rehabilitation and Prevention at 40 Years and Its Role in Promoting Lifestyle Medicine for Prevention of Cardiovascular Diseases: PART 1. Jornal of Cardiopulmonary Rehabilitation and Prevention. 2020;40(3):131-7. doi:10.1097/HCR.0000000000000514.

23. Franklin BA, Brubaker PH, Harber MP, et al. The Journal of Cardiopulmonary Rehabilitation and Prevention at 40 Years and Its Role in Promoting Lifestyle Medicine for Prevention of Cardiovascular Diseases: PART 2. Jornal of Cardiopulmonary Rehabilitation and Prevention. 2020;40(4):209-14. doi:10.1097/HCR.0000000000000523.

24. Pogosova NV, Boytsov SA. Preventive cardiology 2024: current problems and development prospects. Kardiologija. 2024;64(1):4-13. (In Russ.)